Royalty Pharma plc (RPRX)

Royalty Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	950.05	477.01	1,711	1,541	1,009	246.2
Short-Term Investments	48.5	18.3	25.72	647.87	1,053	94.46
Cash & Short-Term Investments	998.55	495.31	1,736	2,189	2,062	340.65
Cash Growth	6.03%	-71.48%	-20.67%	6.16%	505.29%	-82.47%
Accounts Receivable	790.67	775.09	727.92	682.66	626.36	491.33
Receivables	790.67	775.09	727.92	682.66	626.36	491.33
Other Current Assets	4.97	3.8	90.52	6.63	8.6	0.09
Total Current Assets	1,794	1,274	2,555	2,878	2,697	832.07
Long-Term Investments	1,237	1,012	735.82	909.59	916.64	636.1
Other Intangible Assets	5.32	1.78	14.5	5.67	28.67	51.72
Long-Term Accounts Receivable	14,968	14,089	13,493	13,718	12,368	10,842
Other Long-Term Assets	37.47	4.74	15.13	4.15	10	87.95
Total Assets	18,042	16,382	16,813	17,516	16,020	12,450
Accounts Payable	22.06	15.17	7.91	5.62	10.78	11.18
Accrued Expenses	38.41	51.68	54.16	57.7	60.75	-
Current Portion of Long-Term Debt	996.94	-	997.51	-	-	291.2
Other Current Liabilities	110.35	94.53	107.2	107.93	236.37	31.04
Total Current Liabilities	1,168	161.38	1,167	171.25	307.89	333.42
Long-Term Debt	6,610	6,135	6,119	7,096	5,817	5,975
Other Long-Term Liabilities	5.58	0.9	2.5	-	-	-
Total Liabilities	7,784	6,298	7,288	7,267	6,124	6,308
Common Stock	0.11	0.11	0.11	0.11	0.1	3,283
Additional Paid-In Capital	4,108	4,011	3,666	3,508	2,866	-
Retained Earnings	2,765	2,518	1,965	2,255	1,921	2,825
Treasury Stock	-2.66	-2.63	-2.81	-2.72	-2.32	-4.27
Comprehensive Income & Other	-	-	-	16.49	34.4	2.09
Total Common Equity	6,870	6,526	5,628	5,777	4,819	6,106
Minority Interest	3,389	3,558	3,897	4,472	5,077	35.88
Shareholders' Equity	10,258	10,084	9,525	10,249	9,896	6,141
Total Liabilities & Equity	18,042	16,382	16,813	17,516	16,020	12,450
Total Debt	7,607	6,135	7,116	7,096	5,817	6,266
Net Cash (Debt)	-6,609	-5,640	-5,380	-4,907	-3,755	-5,926
Net Cash Per Share	-11.09	-9.35	-12.28	-11.83	-10.00	-
Filing Date Shares Outstanding	444.3	446.69	443.17	432.96	388.13	-
Total Common Shares Outstanding	446.04	446.69	443.17	432.96	388.14	-
Working Capital	626.44	1,113	1,388	2,707	2,389	498.66
Book Value Per Share	15.40	14.61	12.70	13.34	12.42	-
Tangible Book Value	6,865	6,525	5,614	5,771	4,790	6,054
Tangible Book Value Per Share	15.39	14.61	12.67	13.33	12.34	-

Source: S&P Capital IQ. Standard template. Financial Sources.